Monoamine Oxidase B inhibitor 2 is a potent, reversible, orally active, and selective monoamine oxidase B (MAO-B) inhibitor with antioxidant and anti-neuroinflammatory activities; it can cross the blood-brain barrier (BBB) and is useful for Parkinson's disease research.